T-Cure Biosciences
Dr. Baker is the John A. Zahm Professor of Structural Biology in the Department of Chemistry and Biochemistry at the University of Notre Dame. At Notre Dame, Dr. Baker directs a world-renowned research laboratory specializing in structural immunology. Through his work, he has made seminal contributions to the understanding of how T cell receptors ‘see’ antigen, the features of TCRs and antigens that promote immunogenicity, and the mechanisms underlying T cell discrimination between self and non-self. His research has been supported by grants from the National Institutes of Health, the National Science Foundation, and the American Cancer Society. He received his Ph.D. from the University of Iowa and completed his postdoctoral fellowship at Harvard University.
This person is not in the org chart
This person is not in any offices
T-Cure Biosciences
Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find the cure for human cancer using its cutting-edge TCR-T technologies. Using its proprietary iSORT TCR discovery platform, T-Cure expects to rapidly grow its pipeline of therapy candidates. The Company believes its TCR holds great promise in treating patients unaddressed by current modalities.